FindTrial
Sign In

Study of defective Gene responsible for Neurodegenerative Disease

Investigation of Neurodegeneration Associated with Defective DNA Break Repair

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/07/009047
Enrollment
100
Registered
2017-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G119- Hereditary ataxia, unspecified Health Condition 2: null- Neurodegenerative disorder (ataxia)

Interventions

None listed

Sponsors

Dr Kapaettu Satyamoorthy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient (irrespective of any sex) suspected to have neurodegenerative diseases including inherited ataxia based on the physical or neurological examination by neurologist; Patients with or without family history of ataxia

Exclusion criteria

Exclusion criteria: Patients with metabolic, infectious, tumor or alcohol-related degeneration; Patients below 18 years of age

Design outcomes

Primary

MeasureTime frame
Identification of pathogenic variantsTimepoint: 3 years—

Secondary

MeasureTime frame
Association of pathogenic variant with neurodegenerative disorder (ataxia)Timepoint: 3 years—

Countries

India

Contacts

Public ContactDr Sanjiban Chakrabarty

School of Life Sciences, Manipal University

ksatyamoorthy@manipal.edu09845718604

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026